A phase 2 study of CART-ddBCMA in multiple myeloma patients
Latest Information Update: 12 May 2023
Price :
$35 *
At a glance
- Drugs Anitocabtagene autoleucel Arcellx (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms iMMagine-2
- 12 May 2023 New trial record